NMX-1

N/A

Report date: 2022/06/27 14:54:59
NME

Base Information

Drug NameNMX-1
Drug Alias NameNMX-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsInterleukin 11 receptor alpha antagonistsAMP-activated protein kinases activators
TargetsSerine/threonine-protein kinase mTORInterleukin 11 receptor alphaAMP-activated protein kinases
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovomedix LLC
China Registration ClassN/A

Develop Information

Active CompaniesNovomedix LLC
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A